Background A large proportion of pulmonary embolism (PE) heritability remains
unexplained, particularly among the East Asian (EAS) population. Our study aims to expand …

Background The incidence of pulmonary embolism complications in the literature ranges
from 10 to 50%, with a 0.5–10% risk of fatal pulmonary embolism. However, the biological …

Objectives: To identify venous thromboembolism (VTE) disease‐susceptibility genes.
Patients and methods: We performed in silico genome wide association scan (GWAS) …

Venous thromboembolism (VTE) is the third most common life-threatening cardiovascular
condition in the United States, with African Americans (AAs) having a 30% to 60% higher …

Background: Recently, several studies showed that the polymorphisms in the coagulation-
related genes might be associated with venous thromboembolism (VTE); however, the …

Background: Venous thromboembolism (VTE) is a life-threatening vascular event with
environmental and genetic determinants. Recent VTE genome-wide association studies …

Previous genetic studies of venous thromboembolism (VTE) have been largely limited to
common variants, leaving the genetic determinants relatively incomplete. We performed an …

Background: In recent years, many studies have found possible links between gene
polymorphisms and venous thromboembolism (VTE). By identifying genetic risk factors …

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To
advance our understanding of the biology contributing to VTE, we conducted a genome …

Venous thromboembolism (VTE) is a common, heritable disease resulting in high rates of
hospitalization and mortality. Yet few associations between VTE and genetic variants, all in …